FDA panel: CT colonography a viable colorectal cancer screening option

The FDA’s Gastroenterology-Urology Devices Panel and Radiological Devices Panel found computed tomography colonography to be a viable tool for the diagnosis of colorectal cancer among asymptomatic patients aged older than 50 years in a joint meeting today.

ACG maintains that colonoscopy is still the gold standard in colorectal cancer screening and prevention. Please read the ACG-ASGE comment letter here. Healio (9/9)